RGEN

Repligen Corporation

156.90 USD
-2.57 (-1.61%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Repligen Corporation stock is up 37.43% since 30 days ago. The next earnings date is Feb 21, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 41.18% of the previous 33 November’s closed higher than October. In the last 9 Unusual Options Trades, there were 7 CALLs, 2 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
12 Oct 19:43 20 Oct, 2023 150.00 CALL 46 2
19 Oct 13:46 20 Oct, 2023 145.00 PUT 249 42
19 Oct 13:55 20 Oct, 2023 145.00 PUT 300 42
30 Oct 16:06 19 Jan, 2024 135.00 CALL 100 4
30 Oct 18:44 19 Jan, 2024 140.00 CALL 94 5
03 Nov 16:57 19 Jan, 2024 160.00 CALL 53 369
15 Nov 15:36 17 Nov, 2023 150.00 CALL 284 328
17 Nov 18:45 19 Jan, 2024 170.00 CALL 128 37
17 Nov 18:48 19 Jan, 2024 175.00 CALL 1000 20

About Repligen Corporation

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company sells its products to life sciences, biopharmaceutical companies; laboratory researchers; and contract manufacturing organizations.

  • UBS
    Thu Nov 2, 15:11
    buy
    confirm
  • Stifel
    Wed Nov 1, 15:37
    buy
    confirm
  • RBC Capital
    Wed Nov 1, 12:50
    buy
    confirm
  • Keybanc
    Wed Nov 1, 05:39
    buy
    confirm